Sangamo Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Sangamo Therapeutics, Inc.‘s stocks are currently a part of 122 hedge funds’ portfolios, which represents 38.45% of the total amount of its stocks outstanding. This makes up a total of 59.35M shares of Sangamo Therapeutics, Inc.. Compared to the previous quarter, the number fell by -42.82% or -44.45M shares fewer. As for the holding position changes, 39.34% (48) of current hedge fund investors increased the number of shares held, 20.49% (25) of current holders sold a part of the shares held, and 10.66% (13) closed the holdings completely. 16 hedge funds are new holders of Sangamo Therapeutics, Inc. stock in Q1 2023, it is 13.11% of total holders.
Hedge funds holding Sangamo Therapeutics (Q2 2018 – Q1 2023)
| Q2 2018 | 207 |
|---|---|
| Q3 2018 | 214 |
| Q4 2018 | 192 |
| Q1 2019 | 182 |
| Q2 2019 | 180 |
| Q3 2019 | 180 |
| Q4 2019 | 186 |
| Q1 2020 | 179 |
| Q2 2020 | 198 |
| Q3 2020 | 204 |
| Q4 2020 | 217 |
| Q1 2021 | 196 |
| Q2 2021 | 191 |
| Q3 2021 | 188 |
| Q4 2021 | 186 |
| Q1 2022 | 187 |
| Q2 2022 | 179 |
| Q3 2022 | 188 |
| Q4 2022 | 175 |
| Q1 2023 | 122 |
Hedge funds changes in Sangamo Therapeutics positions (Q2 2018 – Q1 2023)
| Q2 2018 | 37 | 95 | 47 | 35 | -7 |
|---|---|---|---|---|---|
| Q3 2018 | 34 | 75 | 59 | 27 | 19 |
| Q4 2018 | 24 | 53 | 77 | 44 | -6 |
| Q1 2019 | 19 | 65 | 54 | 29 | 15 |
| Q2 2019 | 33 | 73 | 39 | 31 | 4 |
| Q3 2019 | 25 | 61 | 40 | 25 | 29 |
| Q4 2019 | 31 | 56 | 56 | 20 | 23 |
| Q1 2020 | 27 | 62 | 47 | 30 | 13 |
| Q2 2020 | 30 | 77 | 47 | 12 | 32 |
| Q3 2020 | 30 | 55 | 69 | 21 | 29 |
| Q4 2020 | 38 | 68 | 71 | 25 | 15 |
| Q1 2021 | 19 | 65 | 71 | 38 | 3 |
| Q2 2021 | 18 | 58 | 74 | 23 | 18 |
| Q3 2021 | 18 | 60 | 64 | 21 | 25 |
| Q4 2021 | 26 | 59 | 59 | 27 | 15 |
| Q1 2022 | 28 | 56 | 56 | 26 | 21 |
| Q2 2022 | 18 | 73 | 45 | 22 | 21 |
| Q3 2022 | 29 | 67 | 47 | 22 | 23 |
| Q4 2022 | 16 | 61 | 58 | 28 | 12 |
| Q1 2023 | 16 | 48 | 25 | 13 | 20 |
Hedge funds changes in Sangamo Therapeutics stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 27,056,000 | 29,569,000 |
|---|---|---|
| Q3 2018 | 35,488,000 | 36,022,000 |
| Q4 2018 | 21,884,000 | 20,542,000 |
| Q1 2019 | 22,588,000 | 14,209,000 |
| Q2 2019 | 26,168,000 | 15,716,000 |
| Q3 2019 | 14,920,000 | 12,107,000 |
| Q4 2019 | 10,531,000 | 13,378,000 |
| Q1 2020 | 7,910,000 | 6,715,000 |
| Q2 2020 | 15,475,000 | 10,509,000 |
| Q3 2020 | 14,093,000 | 10,951,000 |
| Q4 2020 | 40,550,000 | 22,432,000 |
| Q1 2021 | 18,701,000 | 12,046,000 |
| Q2 2021 | 16,899,000 | 11,043,000 |
| Q3 2021 | 10,038,000 | 7,842,000 |
| Q4 2021 | 7,572,000 | 5,100,000 |
| Q1 2022 | 3,641,000 | 1,952,000 |
| Q2 2022 | 2,560,000 | 1,543,000 |
| Q3 2022 | 2,452,000 | 1,974,000 |
| Q4 2022 | 1,180,886 | 638,558 |
| Q1 2023 | 8,142,000 | 17,635,000 |